Role of Soy Supplementation in Prostate Cancer Development

Completed · Phase 3 · Has a placebo group

Conditions studied: Prostate Neoplasm

In brief

This is a randomized study evaluating the effectiveness and direct effect a commercial soy supplement has on prostate cancer and normal prostate tissue. Patient will be randomized it either receive placebo or a commercial soy supplement for 2-4 weeks prior to the planned surgery for treatment of their prostate cancer. Patient's blood and prostate tissue will be evaluated to determine the effects of the soy supplement on the prostate tissue.

Key facts

Study ID
NCT00255125
Run by
VA Office of Research and Development
People needed
86
Starts
2005-09-01
Expected to finish
2009-10-01
Last updated by the study team
2019-06-18

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.